Literature DB >> 9066352

Oculomotor nerve and muscle abnormalities in congenital fibrosis of the extraocular muscles.

E C Engle1, B C Goumnerov, C A McKeown, M Schatz, D R Johns, J D Porter, A H Beggs.   

Abstract

Congenital fibrosis of the extraocular muscles is an autosomal dominant congenital disorder characterized by bilateral ptosis, restrictive external ophthalmoplegia with the eyes partially or completely fixed in an infraducted (downward) and strabismic position, and markedly limited and aberrant residual eye movements. It has been generally thought that these clinical abnormalities result from myopathic fibrosis of the extraocular muscles. We describe the intracranial and orbital pathology of 1 and the muscle pathology of 2 other affected members of a family with chromosome 12-linked congenital fibrosis of the extraocular muscles. There is an absence of the superior division of the oculomotor nerve and its corresponding alpha motor neurons, and abnormalities of the levator palpebrae superioris and rectus superior (the muscles innervated by the superior division of the oculomotor nerve). In addition, increased numbers of internal nuclei and central mitochondrial clumping are found in other extraocular muscles, suggesting that the muscle pathology extends beyond the muscles innervated by the superior division of cranial nerve III. This report presents evidence that congenital fibrosis of the extraocular muscles results from an abnormality in the development of the extraocular muscle lower motor neuron system.

Entities:  

Mesh:

Year:  1997        PMID: 9066352     DOI: 10.1002/ana.410410306

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  39 in total

Review 1.  [Congenital fibrosis of extraocular muscles (CFEOM) and other phenotypes of congenital cranial dysinnervation syndromes (CCDD)].

Authors:  Frank Hanisch; Viktoria Bau; Stephan Zierz
Journal:  Nervenarzt       Date:  2005-04       Impact factor: 1.214

Review 2.  The genetics of strabismus.

Authors:  M Michaelides; A T Moore
Journal:  J Med Genet       Date:  2004-09       Impact factor: 6.318

3.  Cerebellar atrophy in congenital fibrosis of the extraocular muscles type 1.

Authors:  Roberto Di Fabio; Giovanna Comanducci; Francesca Piccolo; Filippo Maria Santorelli; Teresa De Berardinis; Alessandra Tessa; Umberto Sabatini; Francesco Pierelli; Carlo Casali
Journal:  Cerebellum       Date:  2013-02       Impact factor: 3.847

4.  Gillies Lecture: ocular motility in a time of paradigm shift.

Authors:  Joseph L Demer
Journal:  Clin Exp Ophthalmol       Date:  2006-12       Impact factor: 4.207

Review 5.  [Congenital cranial dysinnervation disorders].

Authors:  C Pieh; W A Lagrèze
Journal:  Ophthalmologe       Date:  2007-12       Impact factor: 1.059

Review 6.  The genetic basis of incomitant strabismus: consolidation of the current knowledge of the genetic foundations of disease.

Authors:  Carolyn P Graeber; David G Hunter; Elizabeth C Engle
Journal:  Semin Ophthalmol       Date:  2013 Sep-Nov       Impact factor: 1.975

7.  Recurrent mutation of the KIF21A gene in Japanese patients with congenital fibrosis of the extraocular muscles.

Authors:  Satoko Shimizu; Akira Okinaga; Toshio Maruo
Journal:  Jpn J Ophthalmol       Date:  2005 Nov-Dec       Impact factor: 2.447

8.  Magnetic resonance imaging of the endophenotype of a novel familial Möbius-like syndrome.

Authors:  Sean Dumars; Caroline Andrews; Wai-Man Chan; Elizabeth C Engle; Joseph L Demer
Journal:  J AAPOS       Date:  2008-05-02       Impact factor: 1.220

Review 9.  Recent progress in understanding congenital cranial dysinnervation disorders.

Authors:  Darren T Oystreck; Elizabeth C Engle; Thomas M Bosley
Journal:  J Neuroophthalmol       Date:  2011-03       Impact factor: 3.042

10.  Congenital abnormalities of cranial nerve development: overview, molecular mechanisms, and further evidence of heterogeneity and complexity of syndromes with congenital limitation of eye movements.

Authors:  Elias I Traboulsi
Journal:  Trans Am Ophthalmol Soc       Date:  2004
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.